Who owns Apnimed, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of APMD from SEC Form 13F filings across 71 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 71 institutions disclosed 31.9M shares of Apnimed, Inc. worth $700.8M — about 113.7% of shares outstanding; the largest disclosed holder is AMERIPRISE FINANCIAL INC. Source: SEC Form 13F filings, parsed by EvidInvest.
71
13F holders
$700.8M
value, 2026 filers
113.7%
of shares outstanding (31.9M sh)
71
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of APMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | AMERIPRISE FINANCIAL INCNEW | 7.8M | $170.4M | 0.0% | 27.8% | new |
| 2 | Alpha Wave Global, LPNEW | 7.1M | $154.6M | 3.6% | 25.2% | new |
| 3 | Tao Capital Management LPNEW | 2.2M | $47.7M | 4.4% | 7.8% | new |
| 4 | Janus Henderson Group Ltd.NEW | 1.6M | $34.2M | 0.0% | 5.6% | new |
| 5 | JPMORGAN CHASE & CONEW | 1.4M | $34.4M | 0.0% | 5.1% | new |
| 6 | NEXPOINT ASSET MANAGEMENT, L.P.NEW | 1.3M | $27.9M | 2.3% | 4.5% | new |
| 7 | Logos Global Management LPNEW | 1.1M | $24.1M | 1.3% | 3.9% | new |
| 8 | JENNISON ASSOCIATES LLCNEW | 1.1M | $23.7M | 0.0% | 3.9% | new |
| 9 | Aberdeen Group plcNEW | 945,078 | $20.7M | 0.0% | 3.4% | new |
| 10 | SECTORAL ASSET MANAGEMENT INCNEW | 942,208 | $20.6M | 13.1% | 3.4% | new |
| 11 | ORBIMED ADVISORS LLCNEW | 925,000 | $20.3M | 0.4% | 3.3% | new |
| 12 | BlackRock, Inc.NEW | 854,817 | $18.7M | 0.0% | 3.1% | new |
| 13 | ALLIANCEBERNSTEIN L.P.NEW | 580,281 | $12.7M | 0.0% | 2.1% | new |
| 14 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 549,830 | $12.0M | 0.0% | 2% | new |
| 15 | CITADEL ADVISORS LLCNEW | 517,646 | $11.3M | 0.0% | 1.8% | new |
| 16 | GEODE CAPITAL MANAGEMENT, LLCNEW | 319,982 | $7.0M | 0.0% | 1.1% | new |
| 17 | Woodline Partners LPNEW | 282,772 | $6.2M | 0.0% | 1% | new |
| 18 | FMR LLCNEW | 280,269 | $6.1M | 0.0% | 1% | new |
| 19 | BANK OF AMERICA CORP /DE/NEW | 264,026 | $5.8M | 0.0% | 0.9% | new |
| 20 | Integral Health Asset Management, LLCNEW | 225,000 | $4.9M | 0.3% | 0.8% | new |
| 21 | STATE STREET CORPNEW | 213,354 | $4.7M | 0.0% | 0.8% | new |
| 22 | UBS Group AGNEW | 181,847 | $4.0M | 0.0% | 0.6% | new |
| 23 | Ghisallo Capital Management LLCNEW | 125,000 | $2.7M | 0.1% | 0.4% | new |
| 24 | MASTERS CAPITAL MANAGEMENT LLCNEW | 125,000 | $2.7M | 0.1% | 0.4% | new |
| 25 | CRCM LPNEW | 117,592 | $2.6M | 1.4% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.